XML 39 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring charges and impairment charges (Tables)
 9 Months Ended
Sep. 30, 2018
Restructuring and Related Activities [Abstract]  
Restructuring and Other Impairment Charges
Restructuring charges (credits) by reportable operating segment, and by all other operating segments in the aggregate, for the three and nine months ended September 30, 2018 and October 1, 2017 are set forth in the following table:   
 
Three Months Ended
 
Nine Months Ended
 
September 30, 2018
 
October 1, 2017
 
September 30, 2018
 
October 1, 2017
 
(Dollars in thousands)
Vascular North America
$
203

 
$
582

 
$
725

 
$
1,663

Interventional North America
(26
)
 
(228
)
 
881

 
4,178

Anesthesia North America
38

 
220

 
164

 
1,031

EMEA
1,520

 
(632
)
 
54,310

 
6,483

All other
229

 
(34
)
 
2,435

 
368

Restructuring charges
$
1,964

 
$
(92
)
 
$
58,515

 
$
13,723

The following tables provide information regarding restructuring and impairment charges (credits) recognized by the Company for the three and nine months ended September 30, 2018 and October 1, 2017: 
Three Months Ended September 30, 2018
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2018 Footprint realignment plan
$
1,119

 
$
145

 
$
1,264

Other restructuring programs (2)
468

 
232

 
700

Restructuring charges
$
1,587

 
$
377

 
$
1,964

Asset impairment charges
—

 
17,245

 
17,245

Restructuring and impairment charges
$
1,587

 
$
17,622

 
$
19,209

Three Months Ended October 1, 2017
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
Restructuring (credits) charges (3)
$
(554
)
 
$
462

 
$
(92
)
Nine Months Ended September 30, 2018
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2018 Footprint realignment plan
$
53,463

 
$
275

 
$
53,738

2016 Footprint realignment plan
2,379

 
417

 
2,796

Other restructuring programs (4)
1,318

 
663

 
1,981

Restructuring charges
$
57,160

 
$
1,355

 
$
58,515

Asset impairment charges
—

 
19,110

 
19,110

Restructuring and impairment charges
$
57,160

 
$
20,465

 
$
77,625

Nine Months Ended October 1, 2017
 
 
 
 
 
 
Termination benefits
 
Other costs (1)
 
Total
 
(Dollars in thousands)
2017 Vascular Solutions integration program
$
4,534

 
$
92

 
$
4,626

2017 EMEA restructuring program
5,822

 
84

 
5,906

2016 Footprint realignment plan
1,099

 
233

 
1,332

Other restructuring programs (5)
1,352

 
507

 
1,859

Restructuring charges
$
12,807

 
$
916

 
$
13,723

(1)
Other costs include facility closure, contract termination, and other exit costs.
(2) Other restructuring programs include the 2016 and 2014 Footprint realignment plans, the 2017 Vascular Solutions integration program, the 2017 EMEA restructuring program and the other 2016 restructuring programs.
(3)
Restructuring charges (credits) include activity related to the 2017 Vascular Solutions integration program, the 2017 EMEA restructuring program, the 2016 and 2014 footprint realignment plans, the 2017 Pyng integration program and the other 2016 restructuring programs. The Company committed to the 2017 Pyng integration program, which relates to the integration of Pyng Medical Corp. (“Pyng”) into the Company, during the second quarter of 2017, following the Company’s acquisition of Pyng in April 2017.
(4) Other restructuring programs include the 2014 Footprint realignment plan, the 2017 Vascular Solutions integration program, the 2017 EMEA restructuring program and the other 2016 restructuring programs.
(5) Other restructuring programs include the 2014 Footprint realignment plan, the 2017 Pyng integration program and the other 2016 restructuring programs.
Summary Of Current Cost Estimates By Major Type Of Cost Table
The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2018 Footprint realignment plan:
Type of expense
Total estimated amount expected to be incurred
Termination benefits
$60 million to $70 million
Other exit costs (1)
$2 million to $4 million
Restructuring charges
$62 million to $74 million
Restructuring related charges (2)
$40 million to $59 million
Total restructuring and restructuring related charges
$102 million to $133 million
(1)
Includes contract termination, facility closure, employee relocation, equipment relocation and outplacement costs.
(2)
Consists of pre-tax charges related to accelerated depreciation and other costs directly related to the plan, primarily project management costs and costs to transfer manufacturing operations to the new locations, as well as a charge associated with the Company’s exit from the facilities that is expected to be imposed by the taxing authority in the affected jurisdiction. Excluding this tax charge, substantially all of the charges are expected to be recognized within costs of goods sold.